Roche Diagnostics Roundup: Gradual Addition To Portfolio

The industry's overall growth has slowed down. Bigger companies are likely to acquire budding diagnostics startups that can bring innovation and new technologies to the table, thereby making a difference. The incremental value addition is likely to be small because we don't expect any dramatic change in diagnostics profit forecast. However, there have been some notable acquisition in recent weeks that are worth talking about. It is interesting to note that while J&J has been trimming its medical...